Science Outran the System We Built Around It
The core message of the session is that scientific capability is accelerating faster than the healthcare, regulatory, manufacturing, and commercial systems built to turn discoveries into products. The opening contrast is stark: a single new drug now takes well over a decade and about $2.6 billion on average to reach market, while AI materials companies can rise from $250 million to $2.6 billion in valuation in nine months. Julia, general partner at Phoenix Court, frames this as the gap she has been investing in for nine years: science is moving at AI speed, but clinical trials, pharma batch processes, and healthcare economics still move far more slowly.
frontier-scienceventure-capitalhealthcare-innovation